A high incidence of late-onset neutropenia following rituximab-containing chemotherapy as a primary treatment of CD20-positive B-cell lymphoma: a single-institution study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples